MPOX VACCINE

WHO Approves Second Mpox Vaccine For Emergency Use

WHO Approves LC16m8 Vaccine to Combat Mpox Outbreaks The World Health Organization (WHO) has granted emergency use listing (EUL) approval for the LC16m8 vaccine, developed by Japanese pharmaceutical company KM Biologics. This marks a significant step in the global fight against mpox, previously known as monkeypox. The approval aims to...